Solid Biosciences Inc.
Status: Publicly traded
Direct answer
Solid Biosciences Inc. is publicly traded on NASDAQ under the ticker SLDB.
Solid Biosciences Inc. is an American biotechnology firm dedicated to creating therapeutic solutions for Duchenne Muscular Dystrophy (DMD). Its most advanced experimental drug, SGT-001, is a gene transfer treatment currently in Phase I/II clinical trials, designed to encourage the production of functional dystrophin protein in patients' muscles. The company is also progressing with SGT-003, which represents a...
Can you invest in Solid Biosciences Inc.?
Yes. Solid Biosciences Inc. trades publicly on NASDAQ as SLDB.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Solid Biosciences Inc.
Detailed equity research is provided by MarketSnap.